Navigation Links
Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
Date:5/21/2008

ing provided under a collaborative agreement between Romark and F. Hoffmann-La Roche Ltd.

Romark recently announced enrollment for its STEALTH C-3 clinical trial, a Phase II randomized, double-blind, placebo-controlled study designed to evaluate the safety and efficacy of nitazoxanide in combination with peginterferon alfa-2a and ribavirin in treatment nave patients with chronic hepatitis C infected with genotype 1. Enrollment for the STEALTH C-3 study began in April 2008 and the trial will enroll 60 patients at 15 centers in the U.S.

The primary objective of STEALTH C-3 is to evaluate sustained virologic response (SVR) with a treatment regimen of 4 weeks of nitazoxanide lead-in therapy followed by 48 weeks of standard of care plus nitazoxanide versus 4 weeks of placebo lead-in followed by 48 weeks of standard of care and placebo.

About Nitazoxanide

Nitazoxanide belongs to a new class of small molecule kinase activators called the thiazolides. Like interferons, thiazolides modulate cell signaling pathways involved in the host cell's innate defense against viruses. Thiazolides can be administered orally and are not associated with side effects commonly associated with use of interferon. Nitazoxanide was discovered by Jean-Francois Rossignol, M.D., Ph.D., Chairman and Chief Science Officer of Romark, and was initially developed by Romark and approved for marketing in the United States as a treatment for cryptosporidiosis. Recent laboratory studies have shown that nitazoxanide does not induce resistance mediated by mutations in the viral genome.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease that is caused by the hepatitis C virus (HCV). It is the most common cause of chronic hepatitis in the U.S. and may eventually lead to cirrhosis, liver cancer and liver failure. The disease is transmitted by contact with HCV-infected blood. A large majority of those infected do not show symptoms, but fatigue, abdominal pa
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
2. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
3. Romark Laboratories Raises $18 Million in Institutional Financing
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
6. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
7. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
8. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
9. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
10. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
11. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 /PRNewswire/ -- Concord Medical Services Holdings ... ), a leading specialty hospital management solution provider ... and diagnostic imaging centers in China ... a multi-year strategic development agreement with The University ... an internationally renowned cancer research, treatment and education ...
(Date:5/6/2015)... May 6, 2015 Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... Jonathan Lloyd Jones to the position of Chief ... Mr. Lloyd Jones brings to the ... business development experience.   Most recently, Mr. Lloyd Jones ...
(Date:5/6/2015)... First programme to ... rilpivirine   ViiV Healthcare today ... trial programme to evaluate the safety and efficacy ... as maintenance therapy for adult patients with HIV. ... evaluating 48 week viral suppression with a two ...
Breaking Medicine Technology:Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 2Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 3Concord Medical Services Signs Multi-year Strategic Collaboration Agreement with MD Anderson Cancer Center 4Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10
... Colo. , June 14 REO, a ... appointed Mark Notarfrancesco to the newly created ... role, Mark will direct all aspects of the company,s ...  Prior to joining REO, Mark served with Intel Corporation ...
... Covance Inc. (NYSE: CVD ) today announced that it will ... Wednesday, June 16, 2010 at 3:00 p.m. (ET) .  Investors may ... to register and download any necessary software, please log on 10 minutes early. ... Covance, with headquarters in Princeton, ...
Cached Medicine Technology:Mark Notarfrancesco Joins REO as VP Manufacturing Operations 2
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com ... give away a deluxe human hair lace wig valued at ... enter on a third-party giveaway tool. The important thing is ... the winner. , The hair is a crown, a reflection ... such a jewel for the past 20 years. Whether it ...
(Date:5/6/2015)... May 06, 2015 The American Water ... period for its prestigious Integrated Water Resources Management (IWRM) ... approach to water resources projects. , An IWRM approach to ... establishment in 1964. In 2014, 12 projects were nominated for ... magazine features not only the 2014 AWRA IWRM Award winner ...
(Date:5/6/2015)... NY (PRWEB) May 06, 2015 ... long-standing organization dedicated to activating and celebrating public ... Champion organization, Highmark Health, as an Outstanding Employee ... with the Jefferson Awards Foundation, are dedicated to ... For nearly a decade, Highmark Health has recognized ...
(Date:5/6/2015)... Herndon, VA (PRWEB) May 06, 2015 ... its CIT GAP Funds has invested in e-Kare, Inc. ... speeds the assessment and monitoring of chronic wounds. , ... burn, and complex surgical wounds that affect over 6.5 ... in 2013 as a spin-off enterprise from the Children’s ...
(Date:5/6/2015)... 06, 2015 When it comes to ... more reputable and respected than those of a physician. ... their physician lose more weight than those who received ... conducted by the University of Georgia and published in ... revealed that patients advised by their physicians dropped more ...
Breaking Medicine News(10 mins):Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 2Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 3
... has been detected throughout the Indonesian capital, Jakarta, with the ... on our research, the virus has spread all over the ... of Indonesia's 30 provinces and has killed seven people., ... could be expected, saying that the virus has spread to ...
... Mass Vaccination to children’s against polio virus is conducted ... in Indonesia which has experienced about 290 polio cases ... officials are planning the third round of vaccination program ... mass polio vaccine programs which has provided vaccination to ...
... of the ever-increasing threat about bird flu worldwide, there has ... the drug.// Ranbaxy Laboratories has become the first Indian company ... Tamiflu. The drug is believed to get shipped to a ... would be invalid. ,We have sent small quantities ...
... suspended by the General Medical Council (GMC) of Britain ... a severe infection in a patient who later died.// ... for failing to act when 31-year-old Sean Phillips fell ... Hospital. ,He was convicted of manslaughter and given ...
... research has found that Scotland's kids continue to have the ... the country's overall dental problems found in children aged less ... note of this and has asked parents to start their ... to prevent dental decay. It is generally accepted that decayed ...
... of bird flu infection and some cities are free from ... regions of Dong Thap and An Giang have been tested ... other regions are free from infection which were the main ... free this time due to wide spread vaccination which was ...
Cached Medicine News:Health News:Bird Flu Alarm In Indonesia 2Health News:Scottish Children Have Worst Dental Health In Europe 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: